Sarah Boyce Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week, 1 day ago
Sarah Boyce has an estimated net worth of at least $33.2 million*, as of Dec. 18, 2024. They own 265,308 shares of RNA stock. They have sold 837,901 shares of RNA stock since 2021, for an estimated $25.4 million.
Sarah Boyce $RNA SEC Form 4 Insider Trading
Sarah Boyce has filed a total of 21 insider trades in $RNA since 2021. Their most recent trade was a sale of 31,855 shares, made on Dec 18, 2024. Their largest trade was a sale of 164,233 shares, made on Jun 13, 2024. We estimate that they now own 265,308 shares of $RNA, worth an estimated $7.8 million.
Insider Trading at $RNA
There have been a total of 81 insider trades reported at $RNA since 2021, with 800,000 shares purchased and 2.0 million shares sold. The most active insider traders in $RNA stock have been Sarah Boyce, Arthur A Levin, and Michael F Maclean. The most recent trade was a sale of 12,742 shares reported by W. Michael Flanagan (CSTO), made on Dec 18, 2024.
History of Insider Stock Trades by Sarah Boyce
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
RNA
|
Sale | 31,855 | Dec 18, 2024 | Dec. 19, 2024, 7:15 p.m. |
|
RNA
|
Sale | 32,880 | Sep 23, 2024 | Sept. 23, 2024, 9:01 p.m. |
|
RNA
|
Sale | 28,000 | Aug 06, 2024 | Aug. 7, 2024, 5:46 p.m. |
|
RNA
|
Sale | 28,000 | Jul 09, 2024 | July 11, 2024, 4:07 p.m. |
|
RNA
|
Sale | 32,074 | Jun 18, 2024 | June 20, 2024, 6:47 p.m. |
|
RNA
|
Sale | 164,233 | Jun 13, 2024 | June 14, 2024, 6:58 p.m. |
|
RNA
|
Sale | 35,767 | Jun 14, 2024 | June 14, 2024, 6:58 p.m. |
|
RNA
|
Sale | 100,000 | Jun 12, 2024 | June 14, 2024, 6:58 p.m. |
|
RNA
|
Sale | 28,000 | Jun 04, 2024 | June 5, 2024, 5:46 p.m. |
|
RNA
|
Sale | 28,000 | May 07, 2024 | May 7, 2024, 9:52 p.m. |
|
RNA
|
Sale | 28,000 | Apr 02, 2024 | April 3, 2024, 6:16 p.m. |
|
RNA
|
Sale | 28,000 | Mar 12, 2024 | March 12, 2024, 5:29 p.m. |
|
RNA
|
Sale | 84,000 | Mar 08, 2024 | March 12, 2024, 5:29 p.m. |
|
RNA
|
Sale | 84,000 | Mar 01, 2024 | March 5, 2024, 5:53 p.m. |
|
RNA
|
Sale | 5,092 | Jan 22, 2024 | Jan. 23, 2024, 4:13 p.m. |
|
RNA
|
Sale | 900 | Feb 01, 2023 | Feb. 3, 2023, 6:26 p.m. |
|
RNA
|
Sale | 3,221 | Feb 03, 2023 | Feb. 3, 2023, 6:26 p.m. |
|
RNA
|
Sale | 45,879 | Feb 02, 2023 | Feb. 3, 2023, 6:26 p.m. |
|
RNA
|
Sale | 35,045 | Aug 24, 2022 | Aug. 26, 2022, 7:29 p.m. |
|
RNA
|
Sale | 14,855 | Aug 25, 2022 | Aug. 26, 2022, 7:29 p.m. |
|
RNA
|
Sale | 100 | Aug 15, 2022 | Aug. 17, 2022, 9:40 p.m. |
$RNA Executives and Stock Owners with Insider Trades
-
Sarah Boyce, President and CEO
-
Arthur A Levin, Chief Scientific Officer
-
Michael F Maclean, Chief Financial Officer
-
W. Michael Flanagan, CSTO
-
Teresa Mccarthy, Chief Human Resources Officer
-
Roderick Wong, MP and CIO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.